VarCov Co’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$450K Sell
47,046
-23,706
-34% -$200K 0.22% 157
2026
Q2
$560K Buy
+70,752
New +$452K 0.21% 167
2026
Q1
– Sell
-31,005
Closed -$243K – 664
2025
Q4
$243K Buy
+31,005
New +$244K 0.1% 369

Other funds holding XERS

VarCov Co's XERS Position: Q3 2026 in Review

VarCov Co reduced its Xeris Biopharma Holdings (XERS) stake by 34% in Q3 2026, selling an estimated $200K and leaving 47,046 shares worth $450K. The position accounts for 0.22% of the portfolio, ranked #157.

VarCov Co first reported a position in XERS in Q4 2025 and has held it in 3 quarters since. The position peaked at $560K in Q2 2026. 249 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • VarCov Co held 47,046 shares of Xeris Biopharma Holdings worth $450K as of Q3 2026.
  • VarCov Co sold 23,706 Xeris Biopharma Holdings shares in Q3 2026, an estimated $200K.
  • Xeris Biopharma Holdings made up 0.22% of VarCov Co's portfolio in Q3 2026, its #157 holding.
  • VarCov Co first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 3 quarters since.
  • VarCov Co's Xeris Biopharma Holdings position peaked at $560K in Q2 2026.
  • 249 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.